Advertisement
Research Article

Genome-Wide Mapping of Susceptibility to Coronary Artery Disease Identifies a Novel Replicated Locus on Chromosome 17

  • Martin Farrall equal contributor,

    equal contributor Contributed equally to this work with: Martin Farrall, Fiona R Green

    Affiliation: Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom

    X
  • Fiona R Green equal contributor,

    equal contributor Contributed equally to this work with: Martin Farrall, Fiona R Green

    Affiliation: School of Biomedical and Molecular Sciences, University of Surrey, Guildford, United Kingdom

    X
  • John F Peden,

    Affiliation: Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom

    X
  • Per G Olsson,

    Affiliation: AstraZeneca AB, Mölndal, Sweden

    X
  • Robert Clarke,

    Affiliation: Clinical Trials Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom

    X
  • Mai-Lis Hellenius,

    Affiliation: Department of Medicine, Karolinska Institute, Stockholm, Sweden

    X
  • Stephan Rust,

    Affiliation: Leibniz—Institut für Arterioskleroseforschung an der Universität Münster, Münster, Germany

    X
  • Jacob Lagercrantz,

    Affiliation: Department of Medicine, Karolinska Institute, Stockholm, Sweden

    X
  • Maria Grazia Franzosi,

    Affiliation: Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy

    X
  • Helmut Schulte,

    Affiliation: Leibniz—Institut für Arterioskleroseforschung an der Universität Münster, Münster, Germany

    X
  • Alisoun Carey,

    Affiliation: Oxagen Limited, Abingdon, Oxfordshire, United Kingdom

    X
  • Gunnar Olsson,

    Affiliation: AstraZeneca AB, Mölndal, Sweden

    X
  • Gerd Assmann,

    Affiliations: Leibniz—Institut für Arterioskleroseforschung an der Universität Münster, Münster, Germany, Institute for Clinical Chemistry and Laboratory Medicine, University Clinics Münster, Münster, Germany

    X
  • Gianni Tognoni,

    Affiliation: Department of Cardiovascular Research, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy

    X
  • Rory Collins,

    Affiliation: Clinical Trials Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, United Kingdom

    X
  • Anders Hamsten,

    Affiliation: Department of Medicine, Karolinska Institute, Stockholm, Sweden

    X
  • Hugh Watkins, on behalf of the PROCARDIS Consortium mail

    To whom correspondence should be addressed. E-mail: hugh.watkins@cardiov.ox.ac.uk

    Affiliation: Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom

    X
  • Published: May 19, 2006
  • DOI: 10.1371/journal.pgen.0020072

Reader Comments (0)

Post a new comment on this article